Research output per year
Research output per year
Fingerprint
Dive into the research topics where Seok-Gu Kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas
Shin, I., Park, Y. W., Ahn, S. S., Kang, S. G., Chang, J. H., Kim, S. H. & Lee, S. K., 2022 Jan, In: Journal of Neuroradiology. 49, 1, p. 59-65 7 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Combinatorial therapeutic effect of inhibitors of aldehyde dehydrogenase and mitochondrial complex i, and the chemotherapeutic drug, temozolomide against glioblastoma tumorspheres
Park, H. H., Park, J., Cho, H. J., Shim, J. K., Moon, J. H., Kim, E. H., Chang, J. H., Kim, S. Y. & Kang, S. G., 2021 Jan 2, In: Molecules. 26, 2, 282.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Correction to: Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas (European Radiology, (2020), 30, 12, (6475-6484), 10.1007/s00330-020-07090-3)
Park, Y. W., Ahn, S. S., Park, C. J., Han, K., Kim, E. H., Kang, S. G., Chang, J. H., Kim, S. H. & Lee, S. K., 2021 Mar, In: European Radiology. 31, 3, p. 1782 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters
Park, Y. W., Ahn, S. S., Kim, E. H., Kang, S. G., Chang, J. H., Kim, S. H., Zhou, J. & Lee, S. K., 2021 Mar, In: Neuroradiology. 63, 3, p. 363-372 10 p.Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus) -
Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging
Park, Y. W., Ahn, S. S., Moon, J. H., Kim, E. H., Kang, S. G., Chang, J. H., Kim, S. H. & Lee, S. K., 2021 Nov, In: Neuroradiology. 63, 11, p. 1811-1822 12 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Press / Media
-
A Breakthrough for Understanding Glioblastoma: Origin Cell...
18/8/9
1 item of Media coverage
Press/Media: Press / Media
-
Origin Cells for Deadly Brain Tumors Identified
18/8/6
1 item of Media coverage
Press/Media: Press / Media
-
Origin cells for deadly brain tumours identified
18/8/3
1 item of Media coverage
Press/Media: Press / Media
-
Breakthrough research gives insights on why glioblastomas regrow even after surgery
18/8/2
1 item of Media coverage
Press/Media: Press / Media
-
A breakthrough for understanding glioblastoma—origin cells for deadly brain tumors identified
18/8/2
1 item of Media coverage
Press/Media: Press / Media